Dormer RL - Search Results

1

Development of substituted Benzo[c]quinolizinium compounds as novel activators of the cystic fibrosis chloride channel.

Becq F, Mettey Y, Gray MA, Galietta LJ, Dormer RL, Merten M, Métayé T, Chappe V, Marvingt-Mounir C, Zegarra-Moran O, Tarran R, Bulteau L, Dérand R, Pereira MM, McPherson MA, Rogier C, Joffre M, Argent BE, Sarrouilhe D, Kammouni W, Figarella C, Verrier B, Gola M, Vierfond JM. Becq F, et al. Among authors: dormer rl. J Biol Chem. 1999 Sep 24;274(39):27415-25. doi: 10.1074/jbc.274.39.27415. J Biol Chem. 1999. PMID: 10488073 Free article.

2

Benzo(c)quinolizinium drugs inhibit degradation of Delta F508-CFTR cytoplasmic domain.

Stratford FL, Pereira MM, Becq F, McPherson MA, Dormer RL. Stratford FL, et al. Among authors: dormer rl. Biochem Biophys Res Commun. 2003 Jan 10;300(2):524-30. doi: 10.1016/s0006-291x(02)02883-8. Biochem Biophys Res Commun. 2003. PMID: 12504115

3

Mucin secretion mediated by the cystic fibrosis gene protein, CFTR.

Pereira MM, Dormer RL, McPherson MA. Pereira MM, et al. Among authors: dormer rl. Biochem Soc Trans. 1995 Nov;23(4):532S. doi: 10.1042/bst023532s. Biochem Soc Trans. 1995. PMID: 8654717 No abstract available.

4

Properties of CFTR activated by the xanthine derivative X-33 in human airway Calu-3 cells.

Bulteau L, Dérand R, Mettey Y, Métayé T, Morris MR, McNeilly CM, Folli C, Galietta LJ, Zegarra-Moran O, Pereira MM, Jougla C, Dormer RL, Vierfond JM, Joffre M, Becq F. Bulteau L, et al. Among authors: dormer rl. Am J Physiol Cell Physiol. 2000 Dec;279(6):C1925-37. doi: 10.1152/ajpcell.2000.279.6.C1925. Am J Physiol Cell Physiol. 2000. PMID: 11078708 Free article.

5

Correction of delF508-CFTR activity with benzo(c)quinolizinium compounds through facilitation of its processing in cystic fibrosis airway cells.

Dormer RL, Dérand R, McNeilly CM, Mettey Y, Bulteau-Pignoux L, Métayé T, Vierfond JM, Gray MA, Galietta LJ, Morris MR, Pereira MM, Doull IJ, Becq F, McPherson MA. Dormer RL, et al. J Cell Sci. 2001 Nov;114(Pt 22):4073-81. doi: 10.1242/jcs.114.22.4073. J Cell Sci. 2001. PMID: 11739639

6

Localisation of wild-type and DeltaF508-CFTR in nasal epithelial cells.

Dormer RL, McNeilly CM, Morris MR, Pereira MM, Doull IJ, Becq F, Mettey Y, Vierfond JM, McPherson MA. Dormer RL, et al. Pflugers Arch. 2001;443 Suppl 1:S117-20. doi: 10.1007/s004240100657. Epub 2001 Jul 13. Pflugers Arch. 2001. PMID: 11845316

7

Abnormalities in intracellular regulation in cystic fibrosis.

McPherson MA, Dormer RL. McPherson MA, et al. Among authors: dormer rl. Br Med Bull. 1992 Oct;48(4):766-84. doi: 10.1093/oxfordjournals.bmb.a072577. Br Med Bull. 1992. PMID: 1281035 Review.

8

Cystic fibrosis gene and mucin secretion.

McPherson MA, Dormer RL. McPherson MA, et al. Among authors: dormer rl. Lancet. 1994 Jan 1;343(8888):7. doi: 10.1016/s0140-6736(94)90872-9. Lancet. 1994. PMID: 7905085 No abstract available.

9

Actions of adenosine A1 and A2 receptor antagonists on CFTR antibody-inhibited beta-adrenergic mucin secretion response.

Pereira MM, Lloyd Mills C, Dormer RL, McPherson MA. Pereira MM, et al. Among authors: dormer rl. Br J Pharmacol. 1998 Oct;125(4):697-704. doi: 10.1038/sj.bjp.0702128. Br J Pharmacol. 1998. PMID: 9831904 Free PMC article.

10

A cyclic nucleotide PDE5 inhibitor corrects defective mucin secretion in submandibular cells containing antibody directed against the cystic fibrosis transmembrane conductance regulator protein.

McPherson MA, Pereira MM, Lloyd Mills C, Murray KJ, Dormer RL. McPherson MA, et al. Among authors: dormer rl. FEBS Lett. 1999 Dec 24;464(1-2):48-52. doi: 10.1016/s0014-5793(99)01672-5. FEBS Lett. 1999. PMID: 10611481 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters